Rezultati pretraživanja
  1. Osobe Vidi sve

  2. 11. tra 2019.

    Please RT! Structural Biology at is looking for a protein expression & purification wizard to join its ranks. Amazing opportunity to join a stunning research environment and help discover new drugs while solving structures!

  3. 5. velj 2019.

    to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with . Xencor To receive $120M Up-front.

  4. 7. ožu 2019.

    in GBM recognized by leading scientist Avi Ashkenazi which concluded that " provide evidence that the CDK inhibitor successfully crossed the blood brain barrier of the tumour bearing animals"

  5. 4. sij 2019.

    Adaptive Biotechnologies Enter into Worldwide Collab & LA w/ to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive

  6. 22. lip 2019.

    Genentech Gives Bank Concert with the familia @ Oracle Park

  7. 5. kol 2019.
    Odgovor korisniku/ci

    👀 Jan 6, 2015👉“A deal announced with points the way for , the personal genetics company backed by [& Mail .RU] billionaire and to become a sustainable business”

  8. 25. ruj 2019.

    Thanks to for promoting the importance of culture. It’s my honor to be one of their speakers.

  9. 4. kol 2019.

    Very interesting article on paying and giving away your / to companies who sell it on!

  10. 22. lip 2019.
  11. 7. ožu 2019.

    today news. Submits Application for Venclexta (Venetoclax ) Plus Gazyva for CLL .. what will do in the future is replace Gazyva from the combination. so may also be a suitor for .. MORE HERE

  12. 22. ožu 2019.

    Our friends at breakdown the latest announcement from / Roche announces an update to the GENERATION HD1 trial after reviewing the ASO open label extension study Full Story:

  13. 26. sij 2019.

    Structural Basis of Inhibition by a Gating-Modifier Spider - ScienceDirect. Congratulations on a great paper from the guys & gals at .

  14. 18. srp 2019.
    Odgovor korisniku/ci

    (A) approved for all forms of MS (B) High efficacy (C) probably safer than natalizumab and alemtuzumab. Can we all agree this drug has the best B/R ratio? 😍

  15. 7. pro 2019.
  16. 6. kol 2019.

    Can’t be more excited about starting my internship at !

  17. 7. pro 2019.

    So excited for ... proud to have 5 presentations, including the one on , which I led while I was at

  18. 19. ožu 2019.

    ’s Tecentriq Wins Approval for ES-SCLC, Its Second of the Month

  19. 22. kol 2019.

    a great panel discussion on issues and opportunity to improve inclusivity in research to get Better Science and Better Medicine. Thanks to our sponsor and

  20. 14. sij

    Can’t believe we said goodbye to today (for real). The 1st grad student - feels like the biggest milestone yet. Can’t wait to see what you do Ryan! Good luck at with ... and ... go 49ers??

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.